News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,362 Results
Type
Article (7997)
Company Profile (142)
Press Release (478222)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166712)
Career Advice (303)
Deals (25738)
Drug Delivery (7)
Drug Development (52799)
Employer Resources (14)
FDA (9749)
Job Trends (8570)
News (238058)
Policy (17880)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (492)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33156)
ALS (114)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (295)
Approvals (10433)
Artificial intelligence (345)
ASCO (160)
Autoimmune disease (228)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6958)
BIO (36)
Biologics (14)
BIOSECURE Act (1)
Biosimilars (119)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (3)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (522)
Cancer (3832)
Cardiovascular disease (230)
Career advice (245)
Career pathing (1)
CAR-T (182)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (497)
Cervical cancer (35)
Clinical research (48167)
Collaboration (1308)
Commercialization (6)
Compensation (1552)
Complete response letters (35)
COVID-19 (766)
CRISPR (65)
C-suite (821)
Cystic fibrosis (87)
Data (5998)
Denatured (4)
Depression (108)
Dermatology (80)
Diabetes (364)
Diagnostics (4230)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (162)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (73779)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88258)
Executive appointments (721)
FDA (12558)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (971)
Gene editing (127)
Generative AI (11)
Gene therapy (341)
GLP-1 (299)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9371)
Hematology (94)
HIV (55)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (111)
Immuno-oncology (62)
Indications (169)
Infectious disease (960)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (266)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (47)
Layoffs (59)
Legal (5195)
Licensing (24)
Liver cancer (46)
Longevity (20)
Lung cancer (555)
Lung diease (8)
Lymphoma (261)
Machine learning (29)
Management (3)
Manufacturing (589)
Marketing (9)
MASH (118)
Medical affairs (2)
Medical device (8697)
Medtech (8860)
Mergers & acquisitions (14423)
Metabolic disorders (740)
mRNA (69)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1892)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (169)
Pain (179)
Pancreatic cancer (213)
Parkinson's disease (211)
Partnered (12)
Patents (509)
Patient advocacy (1)
Patient recruitment (534)
Patient selection (14)
Peanut (33)
People (41415)
Peptides (5)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15550)
Phase 2 (21511)
Phase 3 (14515)
Pipeline (7951)
Policy (18)
Postmarket research (1570)
Preclinical (6566)
Press Release (34)
Prostate cancer (196)
Psychedelics (9)
Radiopharmaceuticals (198)
Rare diseases (601)
Real estate (3024)
Recruiting (6)
Regenerative medicine (7)
Regulatory (15052)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (44)
RNA editing (7)
RSV (48)
Schizophrenia (104)
Series A (170)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (337)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (91)
Date
Last 7 days (350)
Last 30 days (1298)
Last 365 days (19024)
2026 (14265)
2025 (19251)
2024 (22988)
2023 (26529)
2022 (34587)
2021 (37152)
2020 (33448)
2019 (23256)
2018 (17460)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21675)
2013 (18135)
2012 (20221)
2011 (20426)
2010 (20332)
Location
Africa (229)
Alabama (80)
Alaska (2)
Arizona (313)
Arkansas (11)
Asia (17995)
Australia (2110)
California (12518)
Canada (3284)
China (556)
Colorado (509)
Connecticut (435)
Delaware (218)
Europe (24724)
Florida (1885)
Georgia (396)
Hawaii (3)
Idaho (46)
Illinois (740)
India (55)
Indiana (326)
Iowa (16)
Japan (437)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1245)
Massachusetts (8196)
Michigan (315)
Minnesota (578)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2747)
New Mexico (12)
New York (2938)
North Carolina (1325)
North Dakota (4)
Northern California (6300)
Ohio (298)
Oklahoma (14)
Oregon (16)
Pennsylvania (2329)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (78)
South Dakota (1)
Southern California (5221)
Tennessee (125)
Texas (2053)
United States (40579)
Utah (377)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (967)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
486,362 Results for "nanoviricides inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
September 29, 2026
·
21 min read
Press Releases
NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering
July 24, 2026
·
4 min read
Press Releases
Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
September 23, 2026
·
14 min read
Press Releases
NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II
May 15, 2026
·
13 min read
Press Releases
NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
May 15, 2026
·
4 min read
Press Releases
Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
September 28, 2026
·
23 min read
Press Releases
Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
September 15, 2026
·
22 min read
Press Releases
Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
May 18, 2026
·
10 min read
Press Releases
NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial
July 28, 2026
·
17 min read
Press Releases
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
August 10, 2026
·
19 min read
1 of 48,637
Next
